Akura Medical, A Shifamed Portfolio Company, Appoints Murali Srivathsa as President and CEO

Written By Shannon Beyer

CAMPBELL, Calif., April 19, 2022 /PRNewswire/ --  Akura Medical, Inc., a Shifamed portfolio company, announced today that seasoned medtech executive, Murali Srivathsa, has joined as President and CEO. With over two decades of industry experience, Murali brings a wealth of medical device and senior leadership expertise. He joins as the team finalizes product development of its next-generation thrombectomy device.

Shannon Beyer
Previous

Route 92 Medical Announces Appointment of Chris Hartman as Chief Commercial Officer
Next

one8o° Placement Round-Up